Larkin v. GlaxoSmithKline LLC

CourtDistrict Court, M.D. Florida
DecidedNovember 19, 2020
Docket8:20-cv-00951
StatusUnknown

This text of Larkin v. GlaxoSmithKline LLC (Larkin v. GlaxoSmithKline LLC) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Larkin v. GlaxoSmithKline LLC, (M.D. Fla. 2020).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION

BRENDA LARKIN,

Plaintiff,

v. Case No. 8:20-cv-951-T-60CPT

GLAXOSMITHKLINE, LLC, a foreign limited liability company,

Defendant. ____________________________________/

ORDER GRANTING IN PART AND DENYING IN PART DEFENDANT’S MOTION TO DISMISS AMENDED COMPLAINT

This matter is before the Court on “Defendant’s Motion to Dismiss Plaintiff’s Amended Complaint or, in the Alternative, for a More Definite Statement and Incorporated Memorandum of Law in Support Thereof,” filed by counsel on August 17, 2020. (Doc. 24). On August 31, 2020, Plaintiff Brenda Larkin filed her response in opposition to the motion. (Doc. 27). After reviewing the motion, response, court file, and the record, the Court finds as follows: Background1 Plaintiff Brenda Larkin is a former sales representative of Defendant GlaxoSmithKline, LLC (“GSK”) and/or its subsidiary GlaxoSmithKline

1 The Court accepts as true the facts alleged in Plaintiff’s amended complaint for purposes of ruling on the pending motion to dismiss. See Erickson v. Pardus, 551 U.S. 89, 94 (2007) (“[W]hen ruling on a defendant’s motion to dismiss, a judge must accept as true all of the factual allegations contained in the complaint.”). The Court is not required to accept as true any legal conclusions couched as factual allegations. See Papasan v. Allain, 478 U.S. 265, 286 (1986).

Pharmaceuticals, Ltd., where she worked from March 2000 until May 24, 2016. According to Plaintiff, over the course of several years, she was subjected to sex-based discrimination and harassment from her supervisor, Jack Jones. Plaintiff details several incidents that occurred between 2014 and 2016, including: being denied a lateral transfer, being singled out during staff meetings, being criticized for conduct

that male co-workers were not criticized for and directed to do, being denied additional duties and opportunities for advancement, and being questioned about her personal life. Plaintiff found Jones’s conduct to be inappropriate and offensive, and she believed that she had no choice but to resign. Legal Standard Federal Rule of Civil Procedure 8(a) requires that a complaint contain “a short

and plain statement of the claim showing the [plaintiff] is entitled to relief.” Fed. R. Civ. P. 8(a). While Rule 8(a) does not demand “detailed factual allegations,” it does require “more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will not do.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007). In order to survive a motion to dismiss, factual allegations must be sufficient “to state a claim to relief that is plausible on its face.” Id. at 570. When deciding a Rule 12(b)(6) motion, review is generally limited to the four

corners of the complaint. Rickman v. Precisionaire, Inc., 902 F. Supp. 232, 233 (M.D. Fla. 1995). Furthermore, when reviewing a complaint for facial sufficiency, a court “must accept [a] [p]laintiff’s well pleaded facts as true, and construe the [c]omplaint in the light most favorable to the [p]laintiff.” Id. (citing Scheuer v. Rhodes, 416 U.S. 232, 236 (1974)). “[A] motion to dismiss should concern only the complaint’s legal sufficiency, and is not a procedure for resolving factual questions or addressing the merits of the case.” Am. Int’l Specialty Lines Ins. Co. v. Mosaic Fertilizer, LLC, 8:09- cv-1264-T-26TGW, 2009 WL 10671157, at *2 (M.D. Fla. Oct. 9, 2009) (Lazzara, J.). Analysis On April 24, 2020, Plaintiff filed her lawsuit against GSK. She asserts two

claims under the Florida Civil Rights Act of 1992 (“FCRA”):2 FCRA Hostile Work Environment Sexual Harassment (Count I) and FCRA Tangible Employment Action Sexual Harassment (Count II). GSK has moved to dismiss the amended complaint, arguing several grounds for relief. Statute of Limitations In its motion, GSK argues that most of Plaintiff’s claims are barred by the

statute of limitations. Specifically, GSK contends that many of the discrete acts identified by Plaintiff in her amended complaint occurred more than four years prior to the filing of the instant suit, with the exception of her alleged constructive discharge. Under Florida law, a plaintiff must file her FCRA claims within four years of the date the claims accrued. See, e.g., Abram-Adams v. Citigroup, Inc., 491 F. App’x 972, 975 (11th Cir. 2012) (citing Seale v. EMSA Corr. Care, Inc., 767 So. 2d 1188, 1189

(Fla. 2000)). However, a plaintiff can avoid the harsh consequences of the limitations period by showing an employment practice that constitutes a continuing violation. Beavers v. Am. Cast Iron Pipe Co., 975 F.2d 792, 796 (11th Cir. 1992). Even though

2 Because the FCRA is patterned after Title VII, federal caselaw addressing Title VII claims also applies to FCRA claims. See, e.g., Kelly v. K.D. Const. of Florida, Inc., 866 F. Supp. 1406, 1411 (S.D. Fla. 1994). the “precise contours and theoretical bases” of the continuing violation theory are unclear at best, “there is general agreement that it relieves a plaintiff of the burden that all actionable conduct must have occurred within [the limitations period], so long as the complaint is timely as to the last occurrence.” Coon v. Georgia Pacific Corp., 829 F.2d 1563, 1570 (11th Cir. 1987) (internal quotation and citation omitted).

The Court finds that, under a continuing violation theory, Plaintiff’s claims are not time-barred. Viewing the facts in light most favorable to Plaintiff, as the Court is required to do at this stage of the proceedings, there is at least a factual issue as to whether the conduct alleged by Plaintiff constitutes a continuing violation where the last known act – her alleged constructive discharge – occurred on May 24, 2016. Consequently, the motion to dismiss is denied as to this ground. Administrative Remedies GSK additionally argues that Counts I and II should be dismissed because

Plaintiff has failed to exhaust her administrative remedies. GSK generally asserts that because the crux of Plaintiff’s EEOC charge was sex discrimination rather than sexual harassment or hostile work environment, she has failed to exhaust her administrative remedies. As a prerequisite to bringing claims under the FCRA, a plaintiff must timely file a charge of discrimination. The Eleventh Circuit has held that “a ‘plaintiff’s judicial

complaint is limited by the scope of the EEOC investigation which can reasonably be expected to grow out of the charge of discrimination.’” Gregory v. Georgia Dept. of Hum. Res., 355 F.3d 1277, 1280 (11th Cir. 2004) (quoting Alexander v. Fulton Cty., Ga., 207 F.3d 1303, 1332 (11th Cir. 2000)). However, courts are “extremely reluctant” to preclude discrimination claims due to procedural technicalities. See id. In her EEOC charge, Plaintiff indicated that the charge was based on sex discrimination that occurred from April 1, 2014, until May 24, 2016. The particulars of the claim include that Plaintiff believed that she and other women were being

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gladys Gregory v. Georgia Dept. of Human Resources
355 F.3d 1277 (Eleventh Circuit, 2004)
Belinda Hulsey v. Pride Restaurants
367 F.3d 1238 (Eleventh Circuit, 2004)
Scheuer v. Rhodes
416 U.S. 232 (Supreme Court, 1974)
Papasan v. Allain
478 U.S. 265 (Supreme Court, 1986)
Burlington Industries, Inc. v. Ellerth
524 U.S. 742 (Supreme Court, 1998)
Faragher v. City of Boca Raton
524 U.S. 775 (Supreme Court, 1998)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Kelly v. K.D. Construction of Florida, Inc.
866 F. Supp. 1406 (S.D. Florida, 1994)
Rickman v. Precisionaire, Inc.
902 F. Supp. 232 (M.D. Florida, 1995)
Seale v. EMSA Correctional Care, Inc.
767 So. 2d 1188 (Supreme Court of Florida, 2000)
Abram-Adams v. Citigroup, Inc.
491 F. App'x 972 (Eleventh Circuit, 2012)
Coon v. Georgia Pacific Corp.
829 F.2d 1563 (Eleventh Circuit, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
Larkin v. GlaxoSmithKline LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/larkin-v-glaxosmithkline-llc-flmd-2020.